Biotechnology News

Dyne Therapeutics CSO sells shares worth over $80,000, a move that has sparked curiosity and raised eyebrows in the biotechnology world. The Chief Scientific Officer (CSO) of a company like Dyne Therapeutics, responsible for leading the research and development of innovative therapies, holds a pivotal role in shaping its future. …

Read More »